| 2026-04-02 | Class I | Under Investigation by firm | Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, d | 271 | |
| 2026-04-02 | Class I | Under Investigation by firm | Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, d | 11,253 | |
| 2026-04-02 | Class I | Under Investigation by firm | Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, d | 4,245 | |
| 2026-03-05 | Class II | Incorrect or no expiration date | Products from the affected device lots were labeled with expiration dates that exceed the true shelf life. | 20 units | |
| 2025-05-15 | Class I | Process change control | Cook Medical identified that catheters supplied in the affected device lots may experience tip separation. | 26986 units | |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 35 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 265 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 10 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 30 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 30 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 145 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 100 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 90 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 10 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 20 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 35 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 25 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 10 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 1,679 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 33 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 98 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 35 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 10 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 195 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 250 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 30 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 60 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 232 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 165 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 311 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 951 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 5 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 20 | 2020-06-30 |
| 2019-10-21 | Class II | Process change control | The potential compromise of the sterility of products from an undersealed chevron in the packaging pouches of Torcon NB Advantage Catheters. | 25 | 2020-06-30 |